BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 27639948)

  • 1. [Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment].
    Huet D; Godbert B; Hermann J; Zordan JM; Chabot F; Andréjak C
    Rev Mal Respir; 2017 Mar; 34(3):257-261. PubMed ID: 27639948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
    Murray MP; Laurenson IF; Hill AT
    Clin Infect Dis; 2008 Jul; 47(2):222-4. PubMed ID: 18532890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
    Andréjak C; Lescure FX; Schmit JL; Jounieaux V
    Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium malmoense: dissemination causes a popliteal aneurysm in a 74-year-old man.
    Brereton AS; El Teraifi H
    BMJ Case Rep; 2012 Apr; 2012():. PubMed ID: 22602841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
    Cadelis G; Ducrot R; Bourdin A; Rastogi N
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mycobacterial pulmonary infection due to Mycobacterium simiae].
    Gaspard W; N'Gampolo I; Rivière F; Lefloch H; Margery J; Marotel C; Soler C; Vaylet F
    Rev Mal Respir; 2016 Mar; 33(3):248-52. PubMed ID: 26282361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment.
    Eur Respir J; 2003 Mar; 21(3):478-82. PubMed ID: 12662005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nine-year progression of untreated pulmonary Mycobacterium szulgai infection.
    Randhawa K; Smethurst P; Soo Hoo GW
    South Med J; 2010 Aug; 103(8):828-30. PubMed ID: 20622732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium shimoidei-cavitary pulmonary disease with favorable outcome.
    Popovic V; Arar D; Popovic DR; Barisic I; Tonkic M; Peric I; Novak A; Rubic Z; Katalinic-Jankovic V; Makek MJ; Goic-Barisic I
    Folia Microbiol (Praha); 2018 Mar; 63(2):249-252. PubMed ID: 28913757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of Mycobacterium malmoense isolation in The Netherlands.
    Hoefsloot W; van Ingen J; de Lange WC; Dekhuijzen PN; Boeree MJ; van Soolingen D
    Eur Respir J; 2009 Oct; 34(4):926-31. PubMed ID: 19386689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
    Davies BS; Roberts CH; Kaul S; Klein JL; Milburn HJ
    Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
    Haworth CS; Floto RA
    Thorax; 2017 Nov; 72(11):969-970. PubMed ID: 29054887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study.
    Gommans EP; Even P; Linssen CF; van Dessel H; van Haren E; de Vries GJ; Dingemans AM; Kotz D; Rohde GG
    Respir Med; 2015 Jan; 109(1):137-45. PubMed ID: 25464905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapulmonary and disseminated infections due to Mycobacterium malmoense: case report and review.
    Zaugg M; Salfinger M; Opravil M; Lüthy R
    Clin Infect Dis; 1993 Apr; 16(4):540-9. PubMed ID: 8390306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on pulmonary lesions in which nontuberculous mycobacteria were detected by percutaneous aspiration--a proposal to add "culture positivity of percutaneous aspiration material" to the bacteriological diagnostic criteria of pulmonary nontuberculous mycobacterial diseases].
    Nakahara Y; Mochizuki Y; Kawamura T; Sasaki S; Morimoto A; Mizumori Y; Tsukamoto H; Watanabe E; Yokoyama T
    Kekkaku; 2013 Mar; 88(3):283-9. PubMed ID: 23672168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease.
    van Ingen J
    Clin Chest Med; 2015 Mar; 36(1):43-54. PubMed ID: 25676518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated mediastinal lymphadenitis caused by Mycobacterium malmoense in an immunocompromised child.
    Sakihama H; Matsubayashi T; Ohkusu K
    J Infect Chemother; 2020 Oct; 26(10):1070-1072. PubMed ID: 32595105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hoarse voice: atypical mycobacterial infection of the larynx.
    McEwan JA; Mohsen AH; Schmid ML; McKendrick MW
    J Laryngol Otol; 2001 Nov; 115(11):920-2. PubMed ID: 11779312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
    Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense].
    Gomez-Abreo D; Prost C; Couraud S; Parmeland L; Carret G; Boibieux A; Gagnieu MC; Gérinière L; Avrillon V; Souquet PJ
    Rev Mal Respir; 2012 Mar; 29(3):435-9. PubMed ID: 22440310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.